vs
CORCEPT THERAPEUTICS INC（CORT）与Ecovyst Inc.（ECVT）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是Ecovyst Inc.的1.0倍（$202.1M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs 11.1%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $22.9M），过去两年Ecovyst Inc.的营收复合增速更高（18.7% vs 17.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
CORT vs ECVT — 直观对比
营收规模更大
CORT
是对方的1.0倍
$199.4M
营收增速更快
ECVT
高出22.8%
11.1%
自由现金流更多
CORT
多$15.5M
$22.9M
两年增速更快
ECVT
近两年复合增速
17.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $199.4M |
| 净利润 | $24.3M | — |
| 毛利率 | 98.7% | 23.4% |
| 营业利润率 | 2.2% | 10.9% |
| 净利率 | 12.0% | — |
| 营收同比 | 11.1% | 34.0% |
| 净利润同比 | -21.0% | — |
| 每股收益（稀释后） | $0.20 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTECVT
| Q4 25 | $202.1M | $199.4M | ||
| Q3 25 | $207.6M | $204.9M | ||
| Q2 25 | $194.4M | $176.1M | ||
| Q1 25 | $157.2M | $143.1M | ||
| Q4 24 | $181.9M | $148.9M | ||
| Q3 24 | $182.5M | $153.9M | ||
| Q2 24 | $163.8M | $154.0M | ||
| Q1 24 | $146.8M | $141.6M |
净利润CORTECVT
| Q4 25 | $24.3M | — | ||
| Q3 25 | $19.7M | $-79.3M | ||
| Q2 25 | $35.1M | $6.0M | ||
| Q1 25 | $20.5M | $-3.6M | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $47.2M | $14.3M | ||
| Q2 24 | $35.5M | $8.3M | ||
| Q1 24 | $27.8M | $1.2M |
毛利率CORTECVT
| Q4 25 | 98.7% | 23.4% | ||
| Q3 25 | 97.8% | 25.4% | ||
| Q2 25 | 98.2% | 22.8% | ||
| Q1 25 | 98.5% | 13.3% | ||
| Q4 24 | 98.4% | 28.9% | ||
| Q3 24 | 98.4% | 29.3% | ||
| Q2 24 | 98.5% | 27.3% | ||
| Q1 24 | 98.3% | 23.5% |
营业利润率CORTECVT
| Q4 25 | 2.2% | 10.9% | ||
| Q3 25 | 4.9% | 13.8% | ||
| Q2 25 | 13.7% | 9.0% | ||
| Q1 25 | 2.2% | -0.7% | ||
| Q4 24 | 13.9% | 15.1% | ||
| Q3 24 | 25.5% | 17.9% | ||
| Q2 24 | 21.7% | 14.1% | ||
| Q1 24 | 20.1% | 9.5% |
净利率CORTECVT
| Q4 25 | 12.0% | — | ||
| Q3 25 | 9.5% | -38.7% | ||
| Q2 25 | 18.1% | 3.4% | ||
| Q1 25 | 13.1% | -2.5% | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 25.9% | 9.3% | ||
| Q2 24 | 21.7% | 5.4% | ||
| Q1 24 | 18.9% | 0.9% |
每股收益（稀释后）CORTECVT
| Q4 25 | $0.20 | $0.06 | ||
| Q3 25 | $0.16 | $-0.69 | ||
| Q2 25 | $0.29 | $0.05 | ||
| Q1 25 | $0.17 | $-0.03 | ||
| Q4 24 | $0.25 | $-0.26 | ||
| Q3 24 | $0.41 | $0.12 | ||
| Q2 24 | $0.32 | $0.07 | ||
| Q1 24 | $0.25 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $197.2M |
| 总债务越低越好 | — | $392.6M |
| 股东权益账面价值 | $647.8M | $603.4M |
| 总资产 | $836.7M | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.65× |
8季度趋势，按日历期对齐
现金及短期投资CORTECVT
| Q4 25 | $372.2M | $197.2M | ||
| Q3 25 | $421.7M | $82.0M | ||
| Q2 25 | $342.2M | $69.6M | ||
| Q1 25 | $322.8M | $127.5M | ||
| Q4 24 | $383.3M | $131.4M | ||
| Q3 24 | $380.3M | $123.5M | ||
| Q2 24 | $473.2M | $83.3M | ||
| Q1 24 | $410.8M | $103.1M |
总债务CORTECVT
| Q4 25 | — | $392.6M | ||
| Q3 25 | — | $854.8M | ||
| Q2 25 | — | $856.6M | ||
| Q1 25 | — | $859.0M | ||
| Q4 24 | — | $860.8M | ||
| Q3 24 | — | $862.7M | ||
| Q2 24 | — | $862.4M | ||
| Q1 24 | — | $866.2M |
股东权益CORTECVT
| Q4 25 | $647.8M | $603.4M | ||
| Q3 25 | $631.9M | $607.9M | ||
| Q2 25 | $635.8M | $692.4M | ||
| Q1 25 | $683.3M | $698.7M | ||
| Q4 24 | $679.6M | $700.5M | ||
| Q3 24 | $638.8M | $729.4M | ||
| Q2 24 | $596.2M | $717.3M | ||
| Q1 24 | $547.9M | $711.4M |
总资产CORTECVT
| Q4 25 | $836.7M | $1.3B | ||
| Q3 25 | $823.6M | $1.7B | ||
| Q2 25 | $801.7M | $1.8B | ||
| Q1 25 | $846.5M | $1.8B | ||
| Q4 24 | $840.6M | $1.8B | ||
| Q3 24 | $784.3M | $1.8B | ||
| Q2 24 | $714.6M | $1.8B | ||
| Q1 24 | $655.9M | $1.8B |
负债/权益比CORTECVT
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.23× | ||
| Q4 24 | — | 1.23× | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $41.8M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $22.9M |
| 自由现金流率自由现金流/营收 | 19.0% | 11.5% |
| 资本支出强度资本支出/营收 | 0.0% | 9.4% |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | $69.9M |
8季度趋势，按日历期对齐
经营现金流CORTECVT
| Q4 25 | $38.4M | $41.8M | ||
| Q3 25 | $54.5M | $55.3M | ||
| Q2 25 | $43.9M | $33.0M | ||
| Q1 25 | $5.1M | $10.3M | ||
| Q4 24 | $59.3M | $43.5M | ||
| Q3 24 | $73.8M | $59.9M | ||
| Q2 24 | $41.2M | $10.0M | ||
| Q1 24 | $23.8M | $36.5M |
自由现金流CORTECVT
| Q4 25 | $38.4M | $22.9M | ||
| Q3 25 | — | $53.2M | ||
| Q2 25 | $43.9M | $7.8M | ||
| Q1 25 | $5.0M | $-14.0M | ||
| Q4 24 | $59.2M | $30.9M | ||
| Q3 24 | $72.2M | $53.6M | ||
| Q2 24 | $40.8M | $-9.3M | ||
| Q1 24 | — | $19.1M |
自由现金流率CORTECVT
| Q4 25 | 19.0% | 11.5% | ||
| Q3 25 | — | 26.0% | ||
| Q2 25 | 22.6% | 4.4% | ||
| Q1 25 | 3.2% | -9.8% | ||
| Q4 24 | 32.5% | 20.7% | ||
| Q3 24 | 39.5% | 34.9% | ||
| Q2 24 | 24.9% | -6.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度CORTECVT
| Q4 25 | 0.0% | 9.4% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 14.4% | ||
| Q1 25 | 0.1% | 16.9% | ||
| Q4 24 | 0.1% | 8.5% | ||
| Q3 24 | 0.9% | 4.1% | ||
| Q2 24 | 0.3% | 12.5% | ||
| Q1 24 | 0.0% | 12.3% |
现金转化率CORTECVT
| Q4 25 | 1.58× | — | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 1.25× | 5.52× | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | 4.21× | ||
| Q2 24 | 1.16× | 1.20× | ||
| Q1 24 | 0.86× | 29.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
